Dr Reddy's in licenses product from Cymbiotics; launches pain relief cream

HYDERABAD: Drug maker Dr. Reddy’s Laboratories launched Supamove Cream for patients suffering from arthritis and joint pains after in licensing the product from US based Cymbiotics. Other brands of Dr Reddy's in the orthopedic segment include Supanac, an oral non-steroidal anti-inflammatory drug (NSAID), and Ruffy, an injectable opiod.

Based in California, Cymbiotics is a bio-pharmaceutical company that designs, develops, validates and introduces innovative disease-specific formulations in pain management and other inflammatory diseases, dermatology, urology and other therapeutic areas. They license their products worldwide.

Another product that Dr Reddy's in-licensed from Cymbiotics was Venusia soft lotion in its emollients and protective product portfolio division. The other products Dr Reddy's in the past in-licensed from Cymbiotics include Celedrin, Ezinapi and GLA-AD

The launch of the new cosmetic products completes Dr. Reddy’s treatment basket in the emollient and protective space which already includes Venusia Cream, Venusia Lotion, Venusia Max and Venusia Bathing Bar. According to research firm IMS, the current market size of Topical NSAID segment in India is over Rs 352 crore with an annual growth rate of 18%.

Other brands of Dr Reddy’s in the topical NSAID segment are Nise gel and Celadrin cream.

The emollients and protectives market in India is currently valued at Rs 208 crore growing at over 18 % annually.